Back to search

Article

A Novel RNA N1-methyladenosine Regulator Mediated Methylation Modification Pattern Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma

2022-11-29

Abstract excerpt

<h4>Background: </h4> Lung adenocarcinoma (LUAD) has a high morbidity and mortality. Although the treatment of NSCLC has made progress in recent years, its 5-year overall survival (OS) is about 25 %. In recent years, epigenetic modification has been increasingly regarded as an important marker of cancer. RNA methylation is essentially an epigenetic modification. However, the potential role of m1A modification-rela...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
02f31752-1b36-5bee-a0c4-020c37178b60
DOI
10.21203/rs.3.rs-2304224/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Novel RNA N1-methyladenosine Regulator Mediated Methylation Modification Pattern Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung AdenocarcinomaDOI 10.21203/rs.3.rs-2304224/v1
Select a neighboring publication to make it the new centre.